HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus (HI ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

CD8-positive T cells are a critical subpopulation of MHC class I-restricted T cell and are mediators of adaptive immunity. They include cytotoxic T cells, which are important for killing cancerous ...

Many of the fears have been fueled by media reports which either overstate the risk of acquiring HIV through accidental occupational needlestick injuries or spotlight cases in which victims are ...

If you're worried about HIV infection, you may wonder whether it's safe to have oral sex. While it's not risk-free, the chances of spreading the virus that causes AIDS are very low if you take the ...

Breakdown of immune privilege in hair follicles leads to infiltration by cytotoxic T cells, particularly CD8+ T cells. Inflammatory cytokines like IFN-γ and TNF-α are key contributors to immune ...

In HIV research, it has shown anti-HIV effects during acute infection and reactivation of latent HIV in chronic infection. As effective CD8+ T cell responses are essential for eliminating reactivated ...

What Is an HIV Rash? An HIV rash is irritated skin that affects people who have HIV. It can be itchy, red or purple, or painful. Most people who have HIV get a rash at some point. It’s a common ...

The future may be getting brighter in terms of reducing the threat of the human immunodeficiency virus (HIV), infectious disease experts told Newsweek. With new treatments and maybe even a vaccine ...

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year. Gilead Sciences, GSK, ViiV Healthcare 1 to 3 years In June 2024, results from a ...

DeGolier et al, Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response, Nature Immunology (2025). DOI: 10.1038/s41590-024-02034-1 ...